Magnetic Resonance Imaging-Guided Interstitial Prostate Brachytherapy
Adenocarcinoma of the prostate is currently the most commonly diagnosed cancer in men in the United States and the second leading cause of cancer mortality (1). The natural history of treated clinically localized and potentially curable disease is often protracted. As a result, side effects sustained from the primary treatment may persist for extended periods, often several decades. Therefore, it is important that the treatment, whose goal is to permanently eradicate the disease, also have acceptable complication rates, leaving the patient with an acceptable quality of life after therapy is complete. To this end, efforts aimed at providing a minimally invasive alternative to radical prostatectomy (RP) for the curative treatment of patients with clinically localized prostate cancer have been made.
KeywordsRadical Prostatectomy Clinical Target Volume Prostate Gland Volume Localize Prostate Cancer Acute Urinary Retention
Unable to display preview. Download preview PDF.
- 6.Cancer, Manual for Staging Cancer, 4th edition. Philadelphia, JP Lippincott, 1997.Google Scholar
- 7.Gleason DF and the Veterans Administration Cooperative Urological Research Group. Histologic grading and staging of prostatic carcinoma, in Urologic Pathology (Tannenbaum M, ed.). Philadelphia, Lea & Febiger; 1977; pp. 171–187.Google Scholar
- 17.Simultaneous inferences and other topics in regression analysis-1, in Applied Linear Regression models, 1st ed (Neter J, Wasserman W, and Kutner M, eds.) Homewood, IL: Richard n. Irwin, Inc..: pp. 150–153.Google Scholar
- 19.D’Amico AV, Schultz D, Silver B, et al. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:679–684.PubMedCrossRefGoogle Scholar